PNPO Antikörper

Produktnummer ABIN2729268

Der Maus Monoklonal Anti-PNPO-Antikörper wurde für WB, IHC und FACS validiert. Er ist geeignet, PNPO in Proben von Human zu detektieren.

Kurzübersicht für PNPO Antikörper (ABIN2729268)

Target: PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser PNPO Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)

Klon: 1G9

Produktdetails anti-PNPO Antikörper

Produktmerkmale: Homo sapiens pyridoxamine 5'-phosphate oxidase (PNPO)

Aufreinigung: Purified from mouse ascites fluids by affinity chromatography

Immunogen: Full length human recombinant protein of human PNPO(NP_060599) produced in HEK293T cell.

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: WB 1:4000, IHC 1:150, FLOW 1:100,

Kommentare:

The concentration of the product may vary between diferrent lots.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5-1.0 mg/mL

Buffer: PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Details zu PNPO

Target: PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))

Andere Bezeichnung: PNPO

Hintergrund: The enzyme encoded by this gene catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. Mutations in this gene result in pyridoxamine 5'-phosphate oxidase (PNPO) deficiency, a form of neonatal epileptic encephalopathy. COMPLETENESS: complete on the 3' end.

Molekulargewicht: 29.8 kDa

Gen-ID: 55163

NCBI Accession: NM_018129

HGNC: 55163